Targeting Src in breast cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Targeting Src in breast cancer

Published:2008-08 Issue:8 Volume:19 Page:1379-1386
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Finn R.S.

Funder

Bristol-Myers Squibb

Wittich Family

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/19/8/1379/628031/mdn291.pdf

Reference73 articles.

1. Steroid receptors and their role in the biology and control of breast cancer growth;Cordera;Semin Oncol,2006

2. Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene;Slamon;Science,1987

3. Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2;Slamon;N Engl J Med,2001

4. Triple-negative breast cancer: therapeutic options;Cleator;Lancet Oncol,2007

5. Molecular portraits of human breast tumours;Perou;Nature,2000

Cited by 208 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Insights into the role of connexins and specialized intercellular communication pathways in breast cancer: Mechanisms and applications;Biochimica et Biophysica Acta (BBA) - Reviews on Cancer;2024-09

2. Discovery of a Covalent Inhibitor Selectively Targeting the Autophosphorylation Site of c-Src Kinase;ACS Chemical Biology;2024-03-21

3. Salvirrane A-F, six undescribed nordrimane sesquiterpene derivatives from Salvia castanea Diels f. tomentosa Stib and their cytotoxic activities;Phytochemistry;2024-02

4. Fucoidan-mediated targeted delivery of dasatinib-loaded nanoparticles amplifies apoptosis and endows cytotoxic potential in triple-negative breast cancer;Colloids and Surfaces B: Biointerfaces;2024-01

5. Selective and Potent PROTAC Degraders of c-Src Kinase;ACS Chemical Biology;2023-12-19

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3